Jeg så gjennomgangen. Synes ikke det var veldig overbevisende. Ta noe så enkelt spm virkningsgraden til ivermetin. Over 80%. Fint og flott, men kanskje du trenger 98% for å få god nok effekt.
Det er jo ikke bare en ny medisin mot covid, men den andre hadde bare 50% så bra effekt. Kanskje ivermetin har 5-10% effekt?
Hva skjer hvis man prøver å kjøre en bil som trenger 98-oktan med 95-oktan bensin? Det er jo to neeeeesten helt like blandinger? Jo du ender opp med motorbank. Iflg samme link som over, så kan du fint bruke noe som ikke er samme molekyl som har noe av samme effekt for å få samme resultat. Det gir rett og slett ikke mening.
Ivermetin
Remsedir
Pfizer sin greie
The same goes for Paxlovid. The 89 percent risk-reduction number comes from 3 out of 389 people who got the drug requiring hospitalization—none died—versus 27 out of the 385 on the placebo arm going to the hospital. (Seven of them died.) That’s statistically significant, but it’s also teeny tiny. “They presented the findings based on early interim analyses, and then press-released the interim analysis. Most Data Safety and Monitoring Committees would not have recommended stopping the trials or making the announcements based on the small number of events that occurred,” says Edward Mills, a health research methods researcher at McMaster University and a leader of the Together Trial, which is testing a bunch of drugs that could be repurposed against Covid. “When you have small event sizes, you end up with dramatic-sounding effects numbers that are not believable.” Mills says that in his trial, the promising drug fluvoxamine had similar early results at an interim analysis, and his DSMC told him to keep going, that it was too early to tell if the numbers were real. (The fluvoxamine turned out to perform pretty well.)
Min utheving. Ser bra ut, men de trenger mer data
